Evidence map›Paper›PMID 40691943›Full record

ArticleJournal of the American Pharmacists Association : JAPhA

Pharmacist roles enhancing substance use disorder treatment access, continuation, and education in a problem-solving court.

Ekaterina Pivovarova, Peter D Friedmann, Joseph Sawicki, Jeffrey Bratberg

Abstract readCase Reports
In one paragraph

Article in Journal of the American Pharmacists Association : JAPhA. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ekaterina Pivovarova
Peter D Friedmann
Joseph Sawicki
Jeffrey Bratberg

Funding

Increasing Referrals to Medications for Opioid Use Disorders from Drug Treatment Courts using Organizational Linkage InterventionK23DA049953 · NIDA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI PIVOVAROVA, EKATERINA · 2020 to 2022
$612k
NIDA NIH HHS K23 DA049953
6 · The paper itself

Abstract

Problem-solving courts (PSCs) are major diversionary programs in the United States criminal legal system, mandating substance use and mental health treatment as an alternative to incarceration. While they reduce recidivism, their impact on clinical outcomes remains uncertain. A significant challenge is ensuring participants have access to and remain in evidence-based medication treatments. Notable barriers to treatment engagement and retention include a lack of relationships between PSCs and community treatment providers, as well as pharmacotherapy expertise. A case study highlights the role of a clinical pharmacist in recovery courts. The pharmacist position was created to address a gap in substance use treatment expertise in recovery courts. The position was funded by a research grant and supplemented by the state court administrative office. The pharmacist role evolved into 5 categories, a liaison between recovery courts and providers; a medication consultant, educating and advising court staff on medications and toxicology test interpretation; court participant care, through medication reviews and adherence support; court educator, providing staff with up-to-date information on new treatments, contaminants, and practical medication considerations; and participant educator on similar issues. The case describes the value of integrating pharmacists in PSCs, enhancing treatment access, participant outcomes, and medication knowledge of court staff.

Indexed as

Health Services AccessibilityPharmacistsProfessional RoleSubstance-Related DisordersHumansPharmaceutical ServicesProblem SolvingUnited States

Identifiers

PMID40691943
PMCPMC12862628

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.